GlaxoSmithKline Consumer Healthcare, Great Britain & Ireland (CHGBI) has outlined its strategy and plans for the coming year. The announcement was made by GSK CHGBI senior executives at the company's annual LIVE+ trade media event, the first since the new organisation was formed in December 2011.
Speaking at the event, Peter Harding, general manager CHGBI said: "GSK is a British company with a fantastic portfolio of brands that British consumers love and trust. Our brands are built on unrivalled scientific expertise and grounded in consumer and shopper understanding.
"Our science, innovation and agility have enabled us to develop an ambitious plan for 2012. This will see the introduction of an unprecedented number of groundbreaking and category-defining new products, underpinned by a significant multi-million pound marketing investment."
Jon Workman, vice president sales CHGBI said: "This year is an incredibly important and exciting time for us as a business but also for our retail partners. 2012 is not only the biggest year in the history of British sport; it is also an opportunity to answer the British consumer's growing demand for products that help them maintain and enhance their health and wellbeing.
"We are perfectly placed to meet shopper and customer needs now and in the future."
Some of the initiatives planned include the unveiling of Lucozade Revive, a light, low-cal energising drink set for launch on 20 February; the introduction of Ribena Plus, a range of no added sugar juice drinks and the brand's biggest launch in 20 years; the launch of two British-inspired variants of the Energy and Sport sub-brands of Lucozade, both with Union flag designs; and Horlicks revealing a limited edition Horlicks Light Chocolate Cherry variant.
Close Window